Method of hormone treatment for patients with symptoms consistent with multiple sclerosis
OwnerEdmund Y.M. Cheininventor
Life of this patent
Estimating the term…
Abstract
A method for patients having symptoms consistent with multiple sclerosis comprising administering a regimen of doses of human growth hormone of less than 0.5 mg/day. In one aspect, the method includes replenishing one or more of melatonin, thymus, thyroid, adrenal and sex hormones to predetermined levels in conjunction with the human growth hormone.
Claims13
A method comprising:
- in a human subject having symptoms consistent with multiple sclerosis, administering a regimen of doses of human growth hormone of less than 0.5 mg. per day.
A method comprising:
- measuring a sample of a human subject's blood, the human subject having symptoms consistent with multiple sclerosis, to determine that the level of human growth hormone is below a predetermined physiological level for an adult human;
- and
- replenishing the level of human growth hormone to the predetermined physiological level.
A kit for treating symptoms associated with multiple sclerosis comprising human growth hormone and at least one of the supplemental hormones selected from the group consisting of sex hormone, melatonin hormone, adrenal hormone, thyroid hormone, and thymus hormone, the kit for establishing a regimen for the replenishment of the human growth hormone and the at least one of the supplemental hormones to predetermined physiological levels.
Dependencies are inferred from the claim text.